RBC Capital Reiterates Rating on Hinge Health, Inc. $HNGE

Written by Podchat · Published · Updated

Editorial illustration for Hinge Health, Inc. (HNGE)

Key Points

  • RBC Capital now rates Hinge Health, Inc. ($HNGE) "buy" with a $75 target.
  • RBC Capital's $75 price target implies 9.73% upside from Hinge Health, Inc.'s ($HNGE) current $68.35 share price.
  • The Street's average $HNGE price target is $106.47 (Buy).
  • $HNGE last traded around $68.35.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

RBC Capital reiterated its rating on Hinge Health, Inc. ($HNGE) to a "buy" rating in a recent research note and set a price target of $75, a 9.73% upside from the current price.

Hinge Health, Inc. Stock Down 21.8%

Shares of Hinge Health, Inc. ($HNGE) traded around $68.35 on Saturday, down 21.8% for the day.

Last price$68.35
Market cap$7.47B
P/E ratio10.63
Forward P/E29.58
52-week low$30.08
52-week high$95.57
50-day MA$83.31
200-day MA$55.55
Current ratio1.34
Quick ratio1.07
Debt-to-equity0.02

Hinge Health, Inc. Earnings

EPS (ttm)$8.71
Revenue (ttm)$720.06M
Revenue growth53%
Net margin15.15%
Return on equity30.38%
Next earningsNov 3, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$106.47
High target$140
Low target$85
Analysts covering15

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

ExchangeNYSE
SectorHealthcare
IndustryHealth Information Services
HeadquartersSan Francisco, CA
CEOMr. Daniel A. Perez
Employees1,437
Websitehttps://www.hingehealth.com

Get Hinge Health, Inc. alerts

New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.

Related Filing Alerts

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.